Cardiac Rehab for Advanced Heart Failure-LVAD Candidates

Overview

  • Study type

    Interventional
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 17-000210
    NCT ID: NCT03132441
    Sponsor Protocol Number: 17-000210

About this study

This study is a pilot study evaluating the feasibility and early efficacy of cardiac rehabilitation to improve frailty and symptoms in patients with advanced heart failure (NYHA class III-IV), who are being considered for LVAD therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Candidate for a Left Ventricular Assist Device (LVAD)
  • Advanced Heart Failure as determined by New York Heart Association classification III or IV

Exclusion Criteria:

  • Unable to perform physical activities required by protocol due to anatomic or musculoskeletal comorbidities
  • Physical activity is contraindicated

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sudhir Kushwaha, M.D.

Open for enrollment

Contact information:

Hannah Frost

(507)293-2762

Frost.Hannah@mayo.edu

.
CLS-20312414

Mayo Clinic Footer